Goodwill in USD of ROCKET PHARMACEUTICALS, INC. from Q4 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
ROCKET PHARMACEUTICALS, INC. quarterly Goodwill history and change rate from Q4 2017 to Q3 2025.
  • ROCKET PHARMACEUTICALS, INC. Goodwill for the quarter ending 30 Sep 2025 was $39,154,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

ROCKET PHARMACEUTICALS, INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $39,154,000 $0 0% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $39,154,000 $0 0% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $39,154,000 $0 0% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $39,154,000 $0 0% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $39,154,000 $0 0% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $39,154,000 $0 0% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $39,154,000 $0 0% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $39,154,000 -$46,000 -0.12% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $39,154,000 +$8,339,000 +27% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $39,154,000 +$8,339,000 +27% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $39,154,000 +$8,339,000 +27% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $39,200,000 +$8,385,000 +27% 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 $30,815,000 $0 0% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $30,815,000 $0 0% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $30,815,000 $0 0% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $30,815,000 $0 0% 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $30,815,000 $0 0% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $30,815,000 $0 0% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $30,815,000 $0 0% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $30,815,000 $0 0% 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $30,815,000 $0 0% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $30,815,000 $0 0% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $30,815,000 $0 0% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $30,815,000 $0 0% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $30,815,000 $0 0% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $30,815,000 $0 0% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $30,815,000 $0 0% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $30,815,000 +$30,815,000 31 Dec 2018 10-K 06 Mar 2020 2019 FY
Q3 2018 $30,815,000 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 $30,815,000 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 $30,815,000 31 Mar 2018 10-Q 11 May 2018 2018 Q1
Q4 2017 $0 31 Dec 2017 10-K 08 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.